Not applicableStudy completedNCT03046329What this trial is testingImproving the Quality of Multiple Myeloma Treatment With Patient Care PlansWho this might be right forMultiple Myeloma Carevive Systems, Inc. 90
Early research (Phase 1)Study completedNCT01318902What this trial is testingStudy of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain AmyloidosisWho this might be right forLight-Chain Amyloidosis Millennium Pharmaceuticals, Inc. 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735637What this trial is testingA Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Who this might be right forNewly Diagnosed Multiple Myeloma (NDMM) AstraZeneca 750
Testing effectiveness (Phase 2)WithdrawnNCT00003605What this trial is testingRituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT04321629What this trial is testingKnee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment MethodsWho this might be right forOsteo Arthritis KneeKnee OsteoarthritisKnee Pain Chronic+4 more Rehasport Clinic 60
Not applicableLooking for participantsNCT06641375What this trial is testingAnti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)Who this might be right forGERD Asian Institute of Gastroenterology, India 18
Early research (Phase 1)Ended earlyNCT00800150What this trial is testingTotal Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more City of Hope Medical Center 6
Testing effectiveness (Phase 2)UnknownNCT05749133What this trial is testingSafety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MMWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory XuYan 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826What this trial is testingTesting Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)UnknownNCT03392714What this trial is testingBendamustine-based Combination Therapy for PCNSLWho this might be right forPCNSL Chonnam National University Hospital 15
Large-scale testing (Phase 3)Study completedNCT02548338What this trial is testingArgon Plasma Coagulation Scalpel on Surgical Treatment of Breast CancerWho this might be right forBreast Neoplasms Federal University of São Paulo 60
Not applicableStudy completedNCT04203784What this trial is testingMeropenem and Piperacillin Plasma Concentrations During CRRTWho this might be right forSepsisInfectionAntibiotic+2 more Karolinska University Hospital 135
Testing effectiveness (Phase 2)Study completedNCT00313625What this trial is testingMelphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)Ended earlyNCT01445197What this trial is testingStudy of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody DevelopmentWho this might be right forHemophilia A CSL Behring 1
Testing effectiveness (Phase 2)Study completedNCT04433910What this trial is testingA Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19Who this might be right forCOVID-19 Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen 106
Large-scale testing (Phase 3)Study completedNCT02419118What this trial is testing"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "Who this might be right forMultiple Myeloma Vejle Hospital 4
Testing effectiveness (Phase 2)Study completedNCT00216697What this trial is testingAn Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib TherapyWho this might be right forMultiple Myeloma Janssen Pharmaceutical K.K. 13
Testing effectiveness (Phase 2)Study completedNCT01510613What this trial is testingPomalidomide and Dexamethasone (PDex) in AL AmyloidosisWho this might be right forPrimary Amyloidosis of Light Chain Type Fondazione IRCCS Policlinico San Matteo di Pavia 28
Not applicableWithdrawnNCT04758260What this trial is testingInfluence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation CycleWho this might be right forCompare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man) IVI Bilbao
Testing effectiveness (Phase 2)Study completedNCT02612779What this trial is testingElotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.Who this might be right forMultiple Myeloma Bristol-Myers Squibb 74